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1. INTRODUCTION {#brb31628-sec-0200}
===============

MDD is a common and debilitating mood disease in the world characterized by pervasive and persistent low mood. It is accompanied by psychological and physiological symptoms, such as lack of motivation, changes in appetite, inability to feel pleasure, cognitive difficulties, and retraction from social interaction (Chan, Cathomas, & Russo, [2019](#brb31628-bib-0004){ref-type="ref"}). The proportion of the global population living with MDD is estimated to be 4.4%, representing the primary cause of disability worldwide (Zhao, Li, Tian, Zhu, & Zhao, [2019](#brb31628-bib-0031){ref-type="ref"}). Although extensive studies have been investigated over the last few decades, the etiology of depression is still not completely explained, which leads to unclear diagnosis and ineffective pharmacotherapy. This may be attributed to insufficient understanding of the pathogenesis of depression (Wu et al., [2016](#brb31628-bib-0027){ref-type="ref"}).

The current consensuses are that depression may be a multifactorial disease with overlapping causal pathways, originating from the environment--gene interaction (Cai et al., [2015](#brb31628-bib-0001){ref-type="ref"}). For example, the sustained stressors to the genetically susceptible individuals lead to the deficits of neuron/glial cells, monoamine, neurotrophic factors, and cytokines, subsequently resulting in the increased risk of the onset or relapse of MDD (Dong et al., [2016](#brb31628-bib-0006){ref-type="ref"}; Huang et al., [2018](#brb31628-bib-0012){ref-type="ref"}). Therefore, numerous hypotheses have been proposed to elucidate its occurrence. Among them, inflammation hypothesis has long been considered as the important pathological mechanism of depression. The evidences from clinical studies have widely demonstrated aberrant inflammation profiles of MDD patients in either central neural system (CNS) or peripheral tissues (Zunszain, Hepgul, & Pariante, [2013](#brb31628-bib-0032){ref-type="ref"}). Additionally, proinflammatory cytokines have shown the influence of pathogenesis of depression and antidepressant therapies, such as neurotransmitter metabolism, neuroendocrine function, and regional brain activity (Carlier et al., [2019](#brb31628-bib-0002){ref-type="ref"}; Guo et al., [2019](#brb31628-bib-0008){ref-type="ref"}; Leonard & Wegener, [2019](#brb31628-bib-0018){ref-type="ref"}). Therefore, chronic low‐grade activation of inflammation and the immune system is likely to be served as a risk factor for the occurrence of depression (Mattina, Van Lieshout, & Steiner, [2019](#brb31628-bib-0020){ref-type="ref"}; Sonsin‐Diaz et al., [2019](#brb31628-bib-0026){ref-type="ref"}; Yin et al., [2019](#brb31628-bib-0029){ref-type="ref"}).

TNF‐α is a cytokine involved in the systematic inflammation and regulated immune cells. Recent meta‐analyses confirmed that the concentration of TNF‐α in depressed patients was considerably higher than that of healthy control (Dowlati et al., [2010](#brb31628-bib-0007){ref-type="ref"}). Accumulated evidence of clinical trials suggested that decreased level of TNF‐α in blood was related to the improvement of depressive symptoms, and additionally, normalizing the blood concentration of TNF‐α with antidepressants or electroconvulsive therapy could successfully cure depression (Howren, Lamkin, & Suls, [2009](#brb31628-bib-0011){ref-type="ref"}). Moreover, inhibition of TNF‐α synthesis through drug blockers can reverse the depressive symptoms of patients (Hannestad, DellaGioia, & Bloch, [2011](#brb31628-bib-0010){ref-type="ref"}). Thus, these evidences identified that TNF‐α was likely to be a potential peripheral biomarker for MDD.

Recently, there is an increasing trend for predicting phenotypes associated with susceptible behavioral or biological factors by functional polymorphisms of regulatory genes in the promoter region. As such, it is credible to speculate that identifying susceptibility genes may eventually lead to targeted "cure therapeutics," giving impetus to identify underlying susceptibility genes associated with MDD. The gene encoding TNF‐α is located on the chromosome 6, which has been reported to be a genetic MDD‐susceptibility region. There are polygene polymorphism loci in TNF‐α gene region (Ma, Zhang, & Baloch, [2016](#brb31628-bib-0019){ref-type="ref"}). In the promoter region of the TNF‐α gene, nucleotide −308 with G to A substitution polymorphism affecting its own genetic transcriptional activity was the most studied. However, the controversial results were obtained from the heterogeneous genetic background that influences by race‐related differences as well as the type of depression.

Thus, we conducted a systematic review and meta‐analysis, including case--control studies comparing TNF‐α G‐308A in patients with depressive disorders versus controls without psychopathology. In this paper, we lay out the results of our meta‐analysis and frame them within the context of the current human literature on TNF‐α G‐308A gene polymorphism and depression susceptibility, providing evidence for the role of TNF‐α G‐308A gene polymorphism in depression and identifying gaps in the literature to inform future research.

2. METHODS AND MATERIALS {#brb31628-sec-0006}
========================

2.1. Identification of eligible studies {#brb31628-sec-0007}
---------------------------------------

Three independent researchers conducted a systematic search in PubMed, Cochrane, Web of Science, and EMBASE databases, and the final search update was on 15 May 2019. The following terms were used: "mood disorders" or "depressive disorder" or "depressive episode" or "depression" and "genetic polymorphism" or "genetic variation" or "genetic variant" or "polymorphism" or "single nucleotide polymorphism" or "variant" and "tumor necrosis factor" or "TNF‐alpha." The language was limited to English. The reference lists of retrieved reports and recent reviews were also manually searched for any additional related articles.

2.2. Inclusion and exclusion criteria {#brb31628-sec-0008}
-------------------------------------

The included studies must satisfy the following criteria: (a) The study utilized a case--control design, and all cases must be clearly diagnosed as depression as well as all controls must not with mental illness; (b) the study examined the associations between TNF‐α G‐308A gene polymorphism and depressive disorders; (c) the data are allowed to be calculated by ORs (odds ratios) and 95% CIs (confidence intervals); and (d) the articles were limited to English language. Research that does not meet the inclusion criteria will be excluded. The selection of studies was completed by two independent investigators (Wang and Cao), through reviewing titles, abstracts, and full text. When disagreement arose, it was decided by all researchers.

2.3. Data extraction and quality assessment {#brb31628-sec-0009}
-------------------------------------------

Data from selected studies were extracted independently by two researchers (Wang and Cao) and then were evaluated in terms of the methodological quality assessment scale. The following details were collected: first author\'s surname, publication year, type of depression, ethnicity of participants, sizes of case sample and control sample, genotyping methods, diagnostic criteria genotype distribution, HWE score, and NOS score. The methodological quality of the eligible researches was assessed by the NOS. Final scores ranged from 0 to 9 points; scores of 0--5 and 6--9 were deemed to be low and high quality, respectively. Divergences were handled by discussion among all researchers.

2.4. Statistics analysis {#brb31628-sec-0010}
------------------------

The software Stata 12.0 and SPSS 21.0 were used to analyze the data. The genotypes' frequencies of control groups were tested by HWE using the chi‐square test. If *p* \> .05, the genotypes' frequency of control groups was consistent with HWE. The following five genetic comparison models were evaluated: allele genetic model (G vs. A), homozygote genetic model (GG vs. AA), heterozygote genetic model (GA vs. GG), recessive genetic model (AA vs. GA + GG), and dominant genetic model (GG vs. AA + GA). The pooled effect size was estimated by ORs and its 95% CI. The heterogeneity between the included studies was based on chi‐square test and *I* ^2^ statistics. If *I* ^2^ \< 50%, it was considered that substantial heterogeneity could be ignored, and then fixed‐effect mode was served to evaluate the pooled ORs and 95% CIs. Apart from this, we performed subgroup analyses by the type of depression. Begg\'s funnel plot was served to evaluate potential publication bias.

3. RESULTS {#brb31628-sec-0011}
==========

3.1. Literature search {#brb31628-sec-0012}
----------------------

The detailed literature search is presented in Figure [1](#brb31628-fig-0001){ref-type="fig"}. We removed 40 duplicate records by EndNote 7.0 software. After browsing the titles and abstracts, we excluded 88 studies due to the following reasons: They were reviews, meeting reports, or protocols. Then, 30 studies were potentially relevant, and we further excluded 21 articles due to the listed reasons: The data of cases or controls were incomplete (*n* = 3); they were not gene--disease association research about the role of TNF‐α G‐308A gene polymorphism played in depressive disorders (*n* = 14); or they were not randomized controlled trial (*n* = 3). Eventually, 9 reports satisfied the criteria were included in this meta‐analysis (Cerri et al., [2010](#brb31628-bib-0003){ref-type="ref"}; Clerici et al., [2009](#brb31628-bib-0005){ref-type="ref"}; Jun et al., [2003](#brb31628-bib-0013){ref-type="ref"}; Kang et al., [2015](#brb31628-bib-0014){ref-type="ref"}; Kim et al., [2012](#brb31628-bib-0017){ref-type="ref"}, [2013](#brb31628-bib-0016){ref-type="ref"}, [2017](#brb31628-bib-0015){ref-type="ref"}; Mihailova et al., [2016](#brb31628-bib-0022){ref-type="ref"}; Sandoval‐Carrillo et al., [2018](#brb31628-bib-0024){ref-type="ref"}). Our study does not require ethical approval.

![Flowchart of the selection of researches and reason for elimination](BRB3-10-e01628-g001){#brb31628-fig-0001}

3.2. Characteristics of the studies {#brb31628-sec-0013}
-----------------------------------

Table [1](#brb31628-tbl-0001){ref-type="table"} summarizes several main factors of the articles selected in this meta‐analysis. These reports were published from 2003 to 2018, consisting of 717 cases and 2,414 controls. Geographically, one study assessed the Caucasian population and eight assessed the Asian population. The frequencies of genotypes in controls were fully in conformity with HWE. We included nine case--control studies as different types of depression, five as major depression, two as postdepression, one as late‐life depression, and one as maternal depression. NOS scores in this meta‐analysis ranged from 5 to 7. The cases were diagnosed using DSM‐IV, GDS, MMSE, GMS B3, and ICD‐10 scales, and 9 studies applied real‐time PCR as the genotyping method.

###### 

Main characteristics of the included studies in the meta‐analysis

  Study                      Year   Disease                 Ethnicity   Sample (Case/Control)   Genotyping   Diagnostic criteria           Cases   Controls   HWE (Controls)   NOS                           
  -------------------------- ------ ----------------------- ----------- ----------------------- ------------ ----------------------------- ------- ---------- ---------------- ----- ----- ---- ------------ ---
  Jun et al                  2003   Major depression        Asian       108/125                 PCR          DSM‐IV                        79      26         3                107   18    0    *p* = .598   6
  Cerri et al.               2010   Major depression        Asian       50/240                  PCR‐SSP      DSM‐IV                        42      8          0                164   65    11   *p* = .682   6
  GDS≧15                                                                                                                                                                                                     
  MMSE≦24                                                                                                                                                                                                    
  Clerici et al.             2009   Major depression        Asian       32/363                  PCR‐SSP      DSM‐IV Physical examination   23      7          1                277   78    5    *p* = .997   6
  Kim et al.                 2012   Poststroke depression   Asian       77/199                  PCR          DSM‐IV                        63      14         0                166   33    0    *p* = .565   5
  Kim et al.                 2013   Late‐life depression    Asian       63/458                  PCR          GMS B3                        50      12         1                373   76    9    *p* = .457   7
  Kang et al.                2015   Major depression        Asian       101/631                 /            GMS B3                        81      17         3                507   114   10   *p* = .707   7
  Mihailova et al.           2016   Major depression        Caucasian   80/52                   PCR‐SSP      ICD‐10                        43      9          0                67    13    0    *p* = .594   5
  Kim et al.                 2017   Poststroke depression   Asian       53/169                  PCR          DSM‐IV                        31      18         4                121   42    6    *p* = .772   6
  Sandoval‐Carrillo et al.   2018   Maternal depression     Asian       153/177                 PCR          /                             136     17         0                160   14    3    *p* = .413   6

John Wiley & Sons, Ltd

3.3. Meta‐analysis of TNF‐α G‐308A gene polymorphism in MDD {#brb31628-sec-0014}
-----------------------------------------------------------

The summary results about meta‐analysis are listed in Table [2](#brb31628-tbl-0002){ref-type="table"}. Our results indicated that significant association was not observed between TNF‐α G‐308A gene polymorphism and depression in five genetic models. ORs with corresponding 95% CIs for the influence of TNF‐a G‐308A gene polymorphism played on depression are detailed in Figures [2](#brb31628-fig-0002){ref-type="fig"}, [3](#brb31628-fig-0003){ref-type="fig"}, [4](#brb31628-fig-0004){ref-type="fig"}, [5](#brb31628-fig-0005){ref-type="fig"}, [6](#brb31628-fig-0006){ref-type="fig"}. There was no statistically difference under five models (G vs. A: OR: 0.87, 95% CI: 0.65--1.16, *p* = .353, Figure [2](#brb31628-fig-0002){ref-type="fig"}; GG vs. AA: OR: 0.80, 95% CI: 0.42--1.52, *p* = .500, Figure [3](#brb31628-fig-0003){ref-type="fig"}; GA vs. GG: OR: 0.87, 95% CI: 0.69--1.10, *p* = .343 Figure [4](#brb31628-fig-0004){ref-type="fig"}, AA vs. GG + GA: OR: 1.23, 95% CI: 0.65--2.34, *p* = .218, Figure [5](#brb31628-fig-0005){ref-type="fig"}; GG vs. GA + AA: OR: 0.87, 95% CI: 0.69--1.09, *p* = .529, Figure [6](#brb31628-fig-0006){ref-type="fig"}).

###### 

Main results in the total analysis

  Group               *I* ^2^, *p* value   OR (95% CI)         *p* value
  ------------------- -------------------- ------------------- -----------
  G versus A          46.2%, 0.062         0.87 (0.65, 1.16)   .353
  GG versus GA        19.7%, 0.279         0.80 (0.42, 1.52)   .500
  GA versus GG        11.0%, 0.343         0.87(0.69, 1.10)    .343
  AA versus GG + GA   10.1%, 0.352         1.23 (0.65, 2.34)   .529
  GG versus GA + AA   33.6%, 0.149         0.87 (0.69, 1.09)   .218

John Wiley & Sons, Ltd

![Forest plots of TNF‐α G‐308‐A gene polymorphism in depression: G allele versus A allele](BRB3-10-e01628-g002){#brb31628-fig-0002}

![Forest plots of TNF‐α G‐308‐A gene polymorphism in depression: GG versus AA](BRB3-10-e01628-g003){#brb31628-fig-0003}

![Forest plots of TNF‐α G‐308‐A gene polymorphism in depression: GG versus GA](BRB3-10-e01628-g004){#brb31628-fig-0004}

![Forest plots of TNF‐α G‐308‐A gene polymorphism in depression: AA versus GG + GA.](BRB3-10-e01628-g005){#brb31628-fig-0005}

![Forest plots of TNF‐α G‐308‐A gene polymorphism in depression: GG versus GA + AA](BRB3-10-e01628-g006){#brb31628-fig-0006}

3.4. Meta‐analysis of TNF‐α G‐308A gene polymorphism in the different types of MDD {#brb31628-sec-0015}
----------------------------------------------------------------------------------

In order to eliminate the effect of the type of depression, we subsequently performed subgroup analyses for each genetic model. The results of the four subtype depressions are presented in Table [3](#brb31628-tbl-0003){ref-type="table"}. For major depression, there was no statistical difference under five genetic models (G vs. A: OR: 0.93, 95% CI: 0.55--1.59; GG vs. AA: OR: 0.72, 95% CI: 0.31--1.67; GA vs. GG: OR: 0.98, 95% CI: 0.72, 1.35; GG vs. GA + AA: OR: 0.95, 95% CI: 0.70--1.29; AA vs. GG + GA: OR: 1.45, 95% CI: 0.62, 3.43).

###### 

Main results in the subgroup analysis

  Type of depression      Number   OR (95% CI) G versus A   OR (95% CI) GG versus AA   OR (95% CI) GA versus GG   OR (95% CI) GG versus GA + AA   OR (95% CI) AA versus GA + GG
  ----------------------- -------- ------------------------ -------------------------- -------------------------- ------------------------------- -------------------------------
  Major depression        5        0.93 (0.55--1.59)        0.72 (0.31--1.67)          0.98 (0.72--1.35)          0.95 (0.70--1.29)               1.45 (0.62--3.43)
  Poststroke depression   2        0.70 (0.46--1.06)        0.38 (0.10--1.45)          0.73 (0.45--1.18)          0.70 ( 0.44--1.11)              2.22 (0.60--8.18)
  Late‐life depression    1        0.92 (0.51--1.67)        1.21 (0.15--9.72)          0.85 (0.43--1.67)          0.88 (0.46--1.69)               0.82 (0.10--6.46)
  Maternal depression     1        1.02 (0.52--1.98)        5.95 (0.305--116.27)       0.70 (0.33--1.47)          0.85 (0.42--1.73)               0.16 (0.01--3.17)

John Wiley & Sons, Ltd

For poststroke depression, there was no statistical difference under five genetic models: (G vs. A: OR: 0.70, 95% CI: 0.46--1.06; GG vs. AA: OR: 0.38, 95% CI: 0.10--1.45; GA vs. GG: OR: 0.73, 95% CI: 0.45--1.18; GG vs. GA + AA: OR: 0.70, 95% CI: 0.44-- 1.11; AA vs. GG + GA: OR: 2.22, 95% CI: 0.60-- 8.18).

For late‐life depression, there was no statistical difference under five genetic models: (G vs. A: OR: 0.92, 95% CI: 0.51--1.67; GG vs. AA: OR: 1.21, 95% CI: 0.15--9.72; GA vs. GG: OR: 0.85, 95% CI: 0.43--1.67; GG vs. GA + AA: OR: 0.88, 95% CI: 0.46--1.69; AA vs. GG + GA: OR: 0.82, 95% CI: 0.10--6.46).

For maternal depression, there was no statistical difference under five genetic models: (G vs. A: OR: 1.02, 95% CI: 0.52--1.98; GG vs. AA: OR: 5.95, 95% CI: 0.305--116.27; GA vs. GG: OR: 0.70, 95% CI: 0.33--1.47; GG vs. GA + AA: OR: 0.85, 95% CI: 0.42--1.73; AA vs. GG + GA: OR: 0.16, 95% CI: 0.01--3.17). Unfortunately, TNF‐α G‐308A gene polymorphism also did not affect the susceptibility of different types of depression.

3.5. Bias analysis and sensitivity analysis {#brb31628-sec-0016}
-------------------------------------------

Taking G versus.A as an example, Begg\'s funnel plot showed that the distribution of each study on both sides of the funnel was basically symmetrical, and Begg\'s test shows that *p* value was greater than .05 (Figure [7](#brb31628-fig-0007){ref-type="fig"}). These results suggested that there was nonsignificant change of publication bias in the current meta‐analysis. Thus, we did not perform the sensitivity analysis.

![Funnel plots of publication bias](BRB3-10-e01628-g007){#brb31628-fig-0007}

4. DISCUSSION {#brb31628-sec-0017}
=============

In the last decade, there is an increasing trend for analyzing functional polymorphisms of regulatory genes in the promoter region to predict phenotypes associated with susceptible behavioral or biological factors (Gupta, Gupta, Bhatia, Tripathi, & Gupta, [2017](#brb31628-bib-0009){ref-type="ref"}). Since the imbalance of inflammatory cytokines involved in the pathogenesis of depressive disorders and SNPs in cytokine genes has a bearing on increased secretion or expression of inflammatory biomarkers, there is increasing evidence of investigating the relationship between SNP in inflammation‐related genes and the risk of MDD (Cytokines, [2016](#brb31628-bib-0019){ref-type="ref"}).

There are growing evidences from clinical and preclinical studies implying that TNF‐α is potentially to play a crucial role in the pathogenesis of depression. At the molecular level, genome‐wide association study suggested that TNF‐α was genetically associated with MDD (Yao et al., [2015](#brb31628-bib-0028){ref-type="ref"}). It has been well established that TNF‐α G‐308A is located in the promoter of TNF‐α and its polymorphism could affect the transcription of TNF‐α production (Richter et al., [2014](#brb31628-bib-0023){ref-type="ref"}). The A allele of this polymorphism can lead to high binding affinity of nuclear factors to the TNF promoter, leading to the high level of transcription activity and secretion levels of TNF‐α. So, TNF‐α G‐308A polymorphism was suggested to be a potential risk factor in the depression episode.

So far, comprehensive investigations concerning the association between TNF‐α gene polymorphisms and susceptibility to depressive disorder have been carried out in various races, especially TNF‐α G‐308A, but the divergences remain as a result of the heterogeneous genetic background among human, the different quantities of cases in these studies, and the complex pathogenesis of depression. The evidence from Jun et al. was that A allele and the AA genotype of the TNF‐α G‐308A had a higher risk of susceptibility to depression in the Korean population (Jun et al., [2003](#brb31628-bib-0013){ref-type="ref"}). On the opposite side, the evidence from Cerri et al indicated that GG genotype was more likely to increase the risk of developing MDD (Cerri et al., [2010](#brb31628-bib-0003){ref-type="ref"}). Besides, Kim et al. demonstrated that GG genotype significantly increased the risk of suicide attempts in MDD (Kim et al., [2012](#brb31628-bib-0017){ref-type="ref"}). Interestingly, it was a well‐known fact that GG genotype was the dominant genotype of the normal population (Merino, Zhang, Kaslow, & Aissani, [2013](#brb31628-bib-0021){ref-type="ref"}). However, several other studies supported that TNF‐α G‐308A gene polymorphism did not have an effect on depression, such as one contrary opinion was that this SNP was not associated with MDD (Clerici et al., [2009](#brb31628-bib-0005){ref-type="ref"}). What\'s more, Sandoval‐Carrillo et al. first evaluated the possible role TNF‐α G‐308A gene polymorphism played in prenatal depression, and the results showed that there was no correlation between them in the Mexican mestizo population (Kim et al., [2017](#brb31628-bib-0015){ref-type="ref"}). Apart from this, higher TNF‐α concentrations were also not associated with TNF‐α G‐308A gene polymorphisms in poststoke depression (Sandoval‐Carrillo et al., [2018](#brb31628-bib-0024){ref-type="ref"}).

A meta‐analysis in 2017 had proved that there was no relationship between this SNP of TNF‐α G‐308A gene and depression (Shin, Jeong, Choi, Kim, & Kim, [2017](#brb31628-bib-0025){ref-type="ref"}). But, the heterozygote genotype of TNF‐α G‐308A gene was not be analyzed. Moreover, the type of depression may affect the susceptibility to depressive disorder. Since some works suggested that there was an association between this SNP and major depression, others indicated that this SNP did not have a bearing on both prenatal depression and poststoke depression (Sandoval‐Carrillo et al., [2018](#brb31628-bib-0024){ref-type="ref"}). Hence, concerning the controversial literature and confusing conclusions, we performed an updated meta‐analysis. We attempted to find the genuine role the allele frequencies and genotypes of this SNP played in depression.

In this study, a total of nine case--control studies encompassing 717 cases and 2,414 controls were included in this meta‐analysis. We performed HWE test on the control groups, and the *p* values of them were all greater than .05. And the NOS scores were all greater than 4 points according to the quality evaluation. It could be considered that the researches were true and reliable. In addition, we also performed Begg\'s test on the included literature, and the result showed that there was no publication bias. We did not find any evidence that the allele frequencies and genotypes of this SNP were related to depression (G vs. A: OR: 0.87, 95% CI: 0.65--1.16, *p* = .353; GG vs. AA: OR: 0.80, 95% CI: 0.42--1.52, *p* = .500; GA vs. GG: OR: 0.87, 95% CI: 0.69--1.10, *p* = .343; GG vs. GA + AA: OR: 0.87, 95% CI: 0.69--1.09, *p* = .529; AA vs. GG + GA: OR: 1.23, 95 CI: 0.65--2.34, *p* = .218).

We also performed subgroup analyses on the type of depression. However, there were still no statistically significant associations in the subgroup analyses, which could first confirm that the connection between TNF‐α G‐308A gene polymorphisms and MDD was not affected by the type of depression. This discrepancy might be due to the small sample size of this meta‐analysis study, especially the small number of cases. Thus, the sampling error could not be ignored. What\'s more, it was a well‐known fact that there was a relationship between depression and the increased TNF‐α plasma level. However, evidence suggested that the genetic predisposition to a higher synthesis of this proinflammatory cytokine was associated with a risk of some physical illnesses rather than depression itself (Mihailova et al., [2016](#brb31628-bib-0022){ref-type="ref"}). Furthermore, a study of Zhang demonstrated that genotypes and alleles of IFN‐λ genes were not associated with HCV infection, but they had a potential effect on biochemical features of HCV patients (Zhang et al., [2014](#brb31628-bib-0030){ref-type="ref"}). Thus, the allele frequencies and genotypes might be connected with the level of TNF‐α instead of the depression.

However, there were still many shortcomings in this meta‐analysis. First, the number of researches we included and the sample sizes of subgroups were limited and the number of cases was less than the controls. Second, depression is influenced by multiple risk factors, such as race, age, sex, and interaction between environment and gene. They all may affect the susceptibility to depressive disorders. The studies we included mainly concerned Asian, elderly and women, which might result in a selective bias. Third, language bias, due to the English limitation in language, some potential researches may be omitted. Nonetheless, this meta‐analysis provides an evaluation about the potential effect that the TNF‐α G‐308A gene polymorphism has on depression.

5. CONCLUSION {#brb31628-sec-0018}
=============

In summary, neither the allele frequencies nor genotypes of TNF‐α G‐308A gene could be served as an independent risk factor of depression. What\'s more, this relationship was also not related to the type of depression. Considering that the incidence of depression is polygenic and it relates to many factors, such as race, environment, gender, and age, the connection between the SNP of TNF‐α G‐308A gene and depression is still required to be set forth by large sample case--control studies.
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